On 11 AUG Chimera Investment Corporation (NYSE:CIM) last released its earnings data on Monday. The company reported $0.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.09 by $0.01. On average, analysts predict that Chimera Investment Corp. will post $0.39 earnings per share for the current fiscal year. Chimera Investment Corporation (NYSE:CIM) belongs to Financial sector. Its net profit margin is 67.20% and weekly performance is -0.92%. On last trading day company shares ended up $3.22. Chimera Investment Corporation (NYSE:CIM) distance from 50-day simple moving average (SMA50) is 1.11%.
Synthetic Biologics Inc. (NYSEMKT: SYN) announced that SYN-004, the Company’s lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile), will be presented at the Infectious Disease Week (IDWeek 2014™) held by the Infectious Diseases Society of America (IDSA), October 8-12, in Philadelphia, PA. Synthetic Biologics Inc. (NYSEMKT: SYN) shares moved up 2.22% in last trading session and ended the day at $2.30. SYN return on assets is -122.50%. Synthetic Biologics Inc. (NYSEMKT: SYN) quarterly performance is 75.57%.
On 5 AUG SunTrust Banks, Inc. (NYSE:STI) announced that Susan Somersille Johnson will join the company as executive vice president and chief marketing officer. She will oversee the company’s brand strategy and marketing operations, reporting to CEO William H. Rogers, Jr.
Johnson was most recently vice president of Global Marketing for NCR Corporation, and previously served as global head of Customer Marketing for Nokia. Prior to that, she held leadership roles in a number of technology organizations. On 25 August, SunTrust Banks, Inc. (NYSE:STI) shares moved up 0.84% and was closed at $38.45. STI EPS growth in last 5 year was 2.60%. SunTrust Banks, Inc. (NYSE:STI) year to date (YTD) performance is 5.28%.
American Lorain Corporation (NYSEMKT: ALN) ended the last trading day at $1.22. Company weekly volatility is calculated as 2.42%and price to cash ratio as 0.92. American Lorain Corporation (NYSEMKT: ALN) showed a weekly performance of 2.52%.
On 7 AUG Sophiris Bio, Inc. (NASDAQ:SPHS) announced financial results and recent key operational and financial highlights for the three and six months ended June 30, 2014. At June 30, 2014, Sophiris had cash, cash equivalents and securities available-for-sale of $35.6 million and working capital of $33.1 million. Sophiris expects that its current cash, cash equivalents and securities available-for-sale as of June 30, 2014 will be sufficient to fund its operations for at least the next 12 months. Sophiris Bio, Inc. (NASDAQ:SPHS) shares moved up 4.17% in last trading session and ended the day on $3.00. SPHS its return on assets is -49.10%. Sophiris Bio, Inc. (NASDAQ:SPHS) quarterly performance is -5.96%.